13th Alzheimers and Parkinsons Drug Development Summit

The 13th Alzheimers and Parkinsons Drug Development Summit is dedicated to CNS Biopharma to Revolutionize the Next Wave of Neurodegenerative Therapeutics.

Topics

• Novel modelling methods to bolster recapitulation of the CNS
• Fortifying the neurodegenerative field: strategic positioning of future pipelines
• Biology & beyond – understanding the fundamentals to map future pathological targets in alzheimer’s
• Mapping clinical study design for efficient timelines in high investment neurodegenerative trials
• Restoring confidence & progressing trust for future neurodegenerative drug development
• Upcoming applications in alzheimer’s disease – varying strategies to approach successful treatment
• The spectrum of technologies employed to boost neuro-discovery
• Tackling the multiple approaches to degenerative disease & enriching modern development tactics